• 0 / 0  
  • United States
  • (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone or 5-fluoro-JWH-122 or 4-methyl-AM-2201
  • Supplier - globalhealth Ltd
  • United StatesUnited States
  • US$1 Million - US$2.5 Million
  • 201 - 300 People
  • Manufacturer,Trading Company,Distributor/Wholesaler
  • North America,South America,Eastern Europe,Southeast Asia,Oceania,Mid East,Eastern Asia,Western Europe
  • Mr.marcos
  • 11-5-299-99425777
Post Date : July 28
Product Details
Company Profile

Item specifics

United States


What is EAM-2201? EAM-2201 ((1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone or 4′-ethyl-AM-2201 or 5″-fluoro-JWH-210) is a potent synthetic cannabinoid agonist which acts at both the CB1 and CB2 receptors. EAM-2201is an analogue of AM-2201 but possesses an ethyl group added to the 4 position of the naphthyl group. It is also closely related to MAM-2201 (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone. By binding to CB1 and CB2 receptors, EAM-2201 like other cannabinoids is believed to activate G-proteins which in turn inhibit N- and P/Q-type voltage-dependent calcium and sodium channels as well as inhibit adenylate cyclase, which inhibits A-type calcium channels. This produces a feeling of euphoria, reduces tiredness, and enhances mood as well as physical and mental performance. What is EAM-2201 used for? EAM-2201 is a research chemical which was first discovered in synthetic cannabis smoking blends in July 2012. Apart from being used recreationally, there are reports that it has successfully been used medicinally by amputees for the management of phantom pain. EAM-2201 is not approved for human use and is available as a crystalline solid. Legality: Please check your local laws before to order. Chemical Data: Identifiers CAS number 1364933-60-7 Yes ATC code ? Chemical data Formula C26H26FNO Mol. mass 387.488 g/mol

Company Related ProductsView the Seller's Products



What is 5-MeO-DALT? 5-MeO-DALT or N,N-diallyl-5-methoxytryptamine or N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine is a relatively new tryptamine and a powerful hallucinogen. It is related to 5-MeO-DPT (5-methoxy-N,N-Dipropyltryptamine) and to DALT (N,N-Diallyltryptamine). 5-MeO-DALT is thought to act like other tryptamines and stimulate the release of serotonin (5-hydroxytryptamine) as well as inhibit its reuptake, while its hallucinogenic and psychedelic effects are believed to be comparable to naturally occurring psilocybin (O-phosphoryl-4-hydroxy-N,N-dimethyltryptamine) and psilocyn (4-HO-DMT). When taken orally, 5-MeO-DALT has been reported to act quickly, which suggests the compound rapidly enters the bloodstream from the digestive tract, while its short duration of action suggests it is promptly metabolised, probably by monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B) like the other tryptamines. Following its administration, some users report tachycardia (increased heart rate), headaches, sweating, retrograde amnesia, insensibility to surroundings, the urge to eat (‘munchies’) as well as hallucinations, although these appear to be less intense than with other tryptamines. What is 5-MeO-DALT used for? 5-MeO-DALT is a research chemical which was first synthesized by Alexander Shulgin. Although its toxicity has yet to be documented, it can be legally purchased in most parts of the world and is not defined as a Class A drug in the UK because it contains an allyl group as opposed to an alkyl group. However, it has not been approved for human consumption. Further research could concentrate on establishing 5-Meo-DALT’s exact mode of action as a probable transporter blocker and / or serotonin receptor agonist. 5-MeO-DALT is available in salt and freebase forms. Legality: Legal in many places, however check your local laws before you order. Chemical Data: Identifiers CAS number 928822-98-4 Yes ATC code ? PubChem CID 50878551 ChemSpider 21106245 Yes Chemical data Formula C17H22N2O Mol. mass 270.375 g/mol

Detail more >>
BAY 38-7271

BAY 38-7271

BAY 38-7271

What is BAY 38-7271? BAY 38-7271 (KN 38-7271 or (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfonate) is a highly potent and highly selective cannabinoid CB1 and CB2 receptor agonist which has been shown to exhibit similar potency to CP 55,940 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-5-(2-methyloctan-2-yl)phenol) in various animal studies. BAY 38-7271 possesses both analgesic and neuroprotective properties when used in the management of Traumatic Brain Injury (TBI), probably via a series of mechanisms instigated at the cannabinoid-receptor level. In addition, the doses required to achieve full neuroprotection with this agonist have been found to be sufficiently low to avoid any of the typical side effects usually associated with the use of cannabinoids. What is BAY 38-7271 used for? BAY 38-7271 was originally developed by Bayer AG before being licensed to KeyNeurotek Pharmaceuticals. This cannabinoid-receptor agonist is still being investigated but Phase II trials showed that it was found to improve the survival rate, cerebral perfusion, and neurological outcome of patients following Traumatic Brain Injury and ischaemic episodes. This drug therefore offers promising advances in the management of TBI and well as cerebral ischaemia. BAY 38-7271 has not been approved for human consumption but can be purchased legally all over the world and is supplied as as white powder. Legality: Please check your local laws. Chemical Data: Identifiers CAS number 212188-60-8 Yes ATC code ? ChemSpider 8021275 Yes ChEMBL CHEMBL1668508 Chemical data Formula C20H21F3O5S Mol. mass 430.437 g/mol

Detail more >>
Talk with SupplierX
matthew marcos:
Can I help you?
Contact Supplier

Selected(1/4)Contact or Compare